Thomas Stephan
Stock Analyst at Stifel
(3.70)
# 787
Out of 4,667 analysts
33
Total ratings
50%
Success rate
10%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Thomas Stephan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLCO Bausch + Lomb | Maintains: Hold | $16 → $19 | $19.62 | -3.16% | 2 | Sep 23, 2024 | |
| GKOS Glaukos | Maintains: Buy | $130 → $145 | $143.28 | +1.20% | 6 | Sep 3, 2024 | |
| STAA STAAR Surgical Company | Maintains: Buy | $50 → $44 | $26.16 | +68.20% | 8 | Aug 26, 2024 | |
| RXST RxSight | Maintains: Buy | $70 → $65 | $45.35 | +43.33% | 6 | Aug 6, 2024 | |
| IRIX IRIDEX | Maintains: Hold | $2 | $1.75 | +14.29% | 2 | May 15, 2024 | |
| ALC Alcon | Reiterates: Buy | $95 → $100 | $85.84 | +16.50% | 4 | May 15, 2024 | |
| SGHT Sight Sciences | Maintains: Buy | $6 → $7 | $3.78 | +85.19% | 5 | Mar 8, 2024 |
Bausch + Lomb
Sep 23, 2024
Maintains: Hold
Price Target: $16 → $19
Current: $19.62
Upside: -3.16%
Glaukos
Sep 3, 2024
Maintains: Buy
Price Target: $130 → $145
Current: $143.28
Upside: +1.20%
STAAR Surgical Company
Aug 26, 2024
Maintains: Buy
Price Target: $50 → $44
Current: $26.16
Upside: +68.20%
RxSight
Aug 6, 2024
Maintains: Buy
Price Target: $70 → $65
Current: $45.35
Upside: +43.33%
IRIDEX
May 15, 2024
Maintains: Hold
Price Target: $2
Current: $1.75
Upside: +14.29%
Alcon
May 15, 2024
Reiterates: Buy
Price Target: $95 → $100
Current: $85.84
Upside: +16.50%
Sight Sciences
Mar 8, 2024
Maintains: Buy
Price Target: $6 → $7
Current: $3.78
Upside: +85.19%